Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro

OBJECTIVE: The aim of the study was to investigate whether lithium chloride and medroxyprogesterone acetate can potentiate the cytotoxicity of imatinib mesylate in human endometrial cancer in vitro and the effect of midkine in these therapies. METHODS: Imatinib mesylate (50 µM), lithium chloride (10...

Descripción completa

Detalles Bibliográficos
Autores principales: Bilir, Ayhan, Erguven, Mine, Ermis, Ezgi, Sencan, Mine, Yazihan, Nuray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Gynecologic Oncology and Colposcopy 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254840/
https://www.ncbi.nlm.nih.gov/pubmed/22247798
http://dx.doi.org/10.3802/jgo.2011.22.4.225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254840/
https://www.ncbi.nlm.nih.gov/pubmed/22247798
http://dx.doi.org/10.3802/jgo.2011.22.4.225

Ejemplares similares